Coronavirus Update: Oxford Racing Ahead With 8,000 Vaccinated In Phase III Trial

Plus: Eisai Joins RE-MAP Cap Study

 
• By Scrip Team
  
Covid19_Carpark
Oxford, UK: The trials led by the university's Jenner Institute have already vaccinated 8,000 subjects
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip